vs
MANGOCEUTICALS, INC.(MGRX)与Quipt Home Medical Corp.(QIPT)财务数据对比。点击上方公司名可切换其他公司
Quipt Home Medical Corp.的季度营收约是MANGOCEUTICALS, INC.的519.4倍($49.0M vs $94.4K)。Quipt Home Medical Corp.净利率更高(-2.1% vs -2935.1%,领先2933.0%)。Quipt Home Medical Corp.同比增速更快(32.3% vs -10.3%)
MANGOCEUTICALS INC是一家专注男士健康护理的企业,研发销售经科学验证的膳食补充剂、男士护肤及护发产品,主要面向美国市场,通过直营电商平台及精选零售渠道为成年男性提供便捷透明的健康护理解决方案。
Quipt Home Medical Corp是一家总部位于美国的家用医疗设备服务商,主营呼吸护理、睡眠治疗用品及慢性病管理相关医疗产品,面向慢性病患者群体提供服务,合作方涵盖医疗机构与保险支付机构。
MGRX vs QIPT — 直观对比
营收规模更大
QIPT
是对方的519.4倍
$94.4K
营收增速更快
QIPT
高出42.6%
-10.3%
净利率更高
QIPT
高出2933.0%
-2935.1%
损益表 — Q4 2025 vs Q1 2026
| 指标 | ||
|---|---|---|
| 营收 | $94.4K | $49.0M |
| 净利润 | $-2.8M | $-1.1M |
| 毛利率 | 50.3% | 53.5% |
| 营业利润率 | -389.7% | 2.1% |
| 净利率 | -2935.1% | -2.1% |
| 营收同比 | -10.3% | 32.3% |
| 净利润同比 | -42.1% | 2.9% |
| 每股收益(稀释后) | $0.38 | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
MGRX
QIPT
| Q4 25 | $94.4K | $49.0M | ||
| Q3 25 | $84.2K | $39.8M | ||
| Q2 25 | $168.1K | $35.1M | ||
| Q1 25 | $109.3K | $33.3M | ||
| Q4 24 | $105.2K | $37.1M | ||
| Q3 24 | $133.4K | — | ||
| Q2 24 | $163.2K | — | ||
| Q1 24 | $214.1K | — |
净利润
MGRX
QIPT
| Q4 25 | $-2.8M | $-1.1M | ||
| Q3 25 | $-7.6M | $-3.5M | ||
| Q2 25 | $-5.4M | $-3.0M | ||
| Q1 25 | $-4.8M | $-3.0M | ||
| Q4 24 | $-1.9M | $-1.1M | ||
| Q3 24 | $-2.0M | — | ||
| Q2 24 | $-2.4M | — | ||
| Q1 24 | $-2.4M | — |
毛利率
MGRX
QIPT
| Q4 25 | 50.3% | 53.5% | ||
| Q3 25 | 60.4% | 48.7% | ||
| Q2 25 | 53.5% | 57.6% | ||
| Q1 25 | 56.8% | 54.6% | ||
| Q4 24 | 76.1% | 52.1% | ||
| Q3 24 | 62.0% | — | ||
| Q2 24 | 42.8% | — | ||
| Q1 24 | 68.8% | — |
营业利润率
MGRX
QIPT
| Q4 25 | -389.7% | 2.1% | ||
| Q3 25 | -8953.5% | -3.6% | ||
| Q2 25 | -3134.0% | -5.2% | ||
| Q1 25 | -4440.0% | -3.0% | ||
| Q4 24 | -1594.0% | 1.2% | ||
| Q3 24 | -1318.2% | — | ||
| Q2 24 | -1329.1% | — | ||
| Q1 24 | -1105.9% | — |
净利率
MGRX
QIPT
| Q4 25 | -2935.1% | -2.1% | ||
| Q3 25 | -9042.8% | -8.9% | ||
| Q2 25 | -3221.6% | -8.6% | ||
| Q1 25 | -4427.4% | -9.1% | ||
| Q4 24 | -1851.2% | -2.9% | ||
| Q3 24 | -1499.0% | — | ||
| Q2 24 | -1465.4% | — | ||
| Q1 24 | -1105.9% | — |
每股收益(稀释后)
MGRX
QIPT
| Q4 25 | $0.38 | $-0.02 | ||
| Q3 25 | $-0.69 | $-0.07 | ||
| Q2 25 | $-0.57 | $-0.07 | ||
| Q1 25 | $-1.29 | $-0.07 | ||
| Q4 24 | $-0.79 | $-0.03 | ||
| Q3 24 | $-1.14 | — | ||
| Q2 24 | $-1.37 | — | ||
| Q1 24 | $-1.50 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $1.5M | $10.5M |
| 总债务越低越好 | — | $84.0M |
| 股东权益账面价值 | $15.2M | $113.0M |
| 总资产 | $16.1M | $280.7M |
| 负债/权益比越低杠杆越低 | — | 0.74× |
8季度趋势,按日历期对齐
现金及短期投资
MGRX
QIPT
| Q4 25 | $1.5M | $10.5M | ||
| Q3 25 | $481.3K | $12.9M | ||
| Q2 25 | $101.0K | $11.3M | ||
| Q1 25 | $76.5K | $17.1M | ||
| Q4 24 | $58.7K | $15.5M | ||
| Q3 24 | $73.9K | — | ||
| Q2 24 | $490.2K | — | ||
| Q1 24 | $15.3K | — |
总债务
MGRX
QIPT
| Q4 25 | — | $84.0M | ||
| Q3 25 | — | $87.6M | ||
| Q2 25 | — | $66.0M | ||
| Q1 25 | — | $71.5M | ||
| Q4 24 | — | $70.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
MGRX
QIPT
| Q4 25 | $15.2M | $113.0M | ||
| Q3 25 | $15.7M | $112.1M | ||
| Q2 25 | $19.2M | $102.5M | ||
| Q1 25 | $20.3M | $103.6M | ||
| Q4 24 | $13.9M | $106.3M | ||
| Q3 24 | $13.4M | — | ||
| Q2 24 | $13.8M | — | ||
| Q1 24 | $-958.4K | — |
总资产
MGRX
QIPT
| Q4 25 | $16.1M | $280.7M | ||
| Q3 25 | $16.5M | $283.3M | ||
| Q2 25 | $20.8M | $236.1M | ||
| Q1 25 | $21.8M | $244.6M | ||
| Q4 24 | $15.4M | $242.8M | ||
| Q3 24 | $14.8M | — | ||
| Q2 24 | $15.2M | — | ||
| Q1 24 | $301.4K | — |
负债/权益比
MGRX
QIPT
| Q4 25 | — | 0.74× | ||
| Q3 25 | — | 0.78× | ||
| Q2 25 | — | 0.64× | ||
| Q1 25 | — | 0.69× | ||
| Q4 24 | — | 0.66× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-1.1M | $8.9M |
| 自由现金流经营现金流 - 资本支出 | — | $6.9M |
| 自由现金流率自由现金流/营收 | — | 14.0% |
| 资本支出强度资本支出/营收 | — | 4.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $26.6M |
8季度趋势,按日历期对齐
经营现金流
MGRX
QIPT
| Q4 25 | $-1.1M | $8.9M | ||
| Q3 25 | $-1.2M | $9.8M | ||
| Q2 25 | $-1.3M | $9.7M | ||
| Q1 25 | $-2.3M | $8.9M | ||
| Q4 24 | $-1.1M | $9.3M | ||
| Q3 24 | $-1.2M | — | ||
| Q2 24 | $-1.6M | — | ||
| Q1 24 | $-991.1K | — |
自由现金流
MGRX
QIPT
| Q4 25 | — | $6.9M | ||
| Q3 25 | — | $8.0M | ||
| Q2 25 | — | $4.4M | ||
| Q1 25 | — | $7.3M | ||
| Q4 24 | — | $5.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率
MGRX
QIPT
| Q4 25 | — | 14.0% | ||
| Q3 25 | — | 20.0% | ||
| Q2 25 | — | 12.6% | ||
| Q1 25 | — | 22.0% | ||
| Q4 24 | — | 15.2% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度
MGRX
QIPT
| Q4 25 | — | 4.2% | ||
| Q3 25 | — | 4.6% | ||
| Q2 25 | — | 14.9% | ||
| Q1 25 | — | 4.8% | ||
| Q4 24 | — | 9.9% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图